OBJECTIVE: To investigate the effects of baseline white matter hyperintensity (WMH) and rates of WMH extension and emergence on rate of change in cognition (episodic memory and executive function). METHODS: A total of 150 individuals including cognitively normal elderly individuals and those with Alzheimer disease and mild cognitive impairment completed serial episodic memory and executive function evaluations and serial MRI scans sufficient for longitudinal measurement of WMH (mean delay 4.0 years). Incident WMH voxels were categorized as extended (baseline WMH that grew larger) or emergent (newly formed WMH). We used a stepwise regression approach to investigate the effects of baseline WMH and rates of WMH extension and emergence on rate of change in cognition (episodic memory and executive function). RESULTS: WMH burden significantly increased over time, and approximately 80% of incident WMH voxels represented extensions of existing lesions. Each 1 mL/y increase in WMH extension was associated with an additional 0.70 SD/y of subsequent episodic memory decrease (p = 0.0053) and an additional 0.55 SD/y of subsequent executive function decrease (p = 0.022). Emergent WMHs were not found to be associated with a change in cognitive measures. CONCLUSIONS: Aging-associated WMHs evolve significantly over a 4-year period. Most of this evolution represents worsening injury to the already compromised surround of existing lesions. Increasing WMH was also significantly associated with declining episodic memory and executive function. This finding supports the view that white matter disease is an insidious and continuously evolving process whose progression has clinically relevant cognitive consequences.
OBJECTIVE: To investigate the effects of baseline white matter hyperintensity (WMH) and rates of WMH extension and emergence on rate of change in cognition (episodic memory and executive function). METHODS: A total of 150 individuals including cognitively normal elderly individuals and those with Alzheimer disease and mild cognitive impairment completed serial episodic memory and executive function evaluations and serial MRI scans sufficient for longitudinal measurement of WMH (mean delay 4.0 years). Incident WMH voxels were categorized as extended (baseline WMH that grew larger) or emergent (newly formed WMH). We used a stepwise regression approach to investigate the effects of baseline WMH and rates of WMH extension and emergence on rate of change in cognition (episodic memory and executive function). RESULTS:WMH burden significantly increased over time, and approximately 80% of incident WMH voxels represented extensions of existing lesions. Each 1 mL/y increase in WMH extension was associated with an additional 0.70 SD/y of subsequent episodic memory decrease (p = 0.0053) and an additional 0.55 SD/y of subsequent executive function decrease (p = 0.022). Emergent WMHs were not found to be associated with a change in cognitive measures. CONCLUSIONS: Aging-associated WMHs evolve significantly over a 4-year period. Most of this evolution represents worsening injury to the already compromised surround of existing lesions. Increasing WMH was also significantly associated with declining episodic memory and executive function. This finding supports the view that white matter disease is an insidious and continuously evolving process whose progression has clinically relevant cognitive consequences.
Authors: P Kochunov; J L Lancaster; P Thompson; R Woods; J Mazziotta; J Hardies; P Fox Journal: J Comput Assist Tomogr Date: 2001 Sep-Oct Impact factor: 1.826
Authors: F-E de Leeuw; J C de Groot; M Oudkerk; J C M Witteman; A Hofman; J van Gijn; M M B Breteler Journal: Brain Date: 2002-04 Impact factor: 13.501
Authors: B Winblad; K Palmer; M Kivipelto; V Jelic; L Fratiglioni; L-O Wahlund; A Nordberg; L Bäckman; M Albert; O Almkvist; H Arai; H Basun; K Blennow; M de Leon; C DeCarli; T Erkinjuntti; E Giacobini; C Graff; J Hardy; C Jack; A Jorm; K Ritchie; C van Duijn; P Visser; R C Petersen Journal: J Intern Med Date: 2004-09 Impact factor: 8.989
Authors: Jan Cees De Groot; Frank-Erik De Leeuw; Matthijs Oudkerk; Jan Van Gijn; Albert Hofman; Jellemer Jolles; Monique M B Breteler Journal: Ann Neurol Date: 2002-09 Impact factor: 10.422
Authors: Ewoud J van Dijk; Monique M B Breteler; Reinhold Schmidt; Klaus Berger; Lars-Göran Nilsson; Matthijs Oudkerk; Andrzej Pajak; Susana Sans; Maria de Ridder; Carole Dufouil; Rebecca Fuhrer; Simona Giampaoli; Lenore J Launer; Albert Hofman Journal: Hypertension Date: 2004-10-04 Impact factor: 10.190
Authors: Adam M Brickman; Laura B Zahodne; Vanessa A Guzman; Atul Narkhede; Irene B Meier; Erica Y Griffith; Frank A Provenzano; Nicole Schupf; Jennifer J Manly; Yaakov Stern; José A Luchsinger; Richard Mayeux Journal: Neurobiol Aging Date: 2014-07-21 Impact factor: 4.673
Authors: Nancy A Kerner; Steven P Roose; Gregory H Pelton; Adam Ciarleglio; Jennifer Scodes; Cody Lentz; Joel R Sneed; D P Devanand Journal: Am J Geriatr Psychiatry Date: 2016-11-17 Impact factor: 4.105
Authors: Pauline Maillard; Evan Fletcher; Baljeet Singh; Oliver Martinez; David K Johnson; John M Olichney; Sarah T Farias; Charles DeCarli Journal: Neurology Date: 2019-04-05 Impact factor: 9.910
Authors: Charles H Brown; A Richey Sharrett; Josef Coresh; Andrea L C Schneider; Alvaro Alonso; David S Knopman; Thomas H Mosley; Rebecca F Gottesman Journal: Neurology Date: 2015-03-11 Impact factor: 9.910
Authors: James C Root; Kane O Pryor; Robert Downey; Yesne Alici; Marcus L Davis; Andrei Holodny; Beatriz Korc-Grodzicki; Tim Ahles Journal: Psychooncology Date: 2013-03-04 Impact factor: 3.894